Dr. Reiss Binder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-615-5858Fax+1 410-662-4646
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
- Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
- Pennsylvania State University College of MedicineClass of 2008
Certifications & Licensure
- PA State Medical License 2015 - 2026
- MD State Medical License 2011 - 2015
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Career Development Award ASCO, 2017
Clinical Trials
- Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC) Start of enrollment: 2017 Mar 30
- Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy Start of enrollment: 2017 Sep 05
Publications & Presentations
PubMed
- 2 citationsCAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.Kim A Reiss, Mathew G Angelos, E Claire Dees, Yuan Yuan, Naoto T Ueno
Nature Medicine. 2025-02-07 - Efficacy of Zenocutuzumab inFusion-Positive Cancer.Alison M Schram, Koichi Goto, Dong-Wan Kim, Teresa Macarulla, Antoine Hollebecque
The New England Journal of Medicine. 2025-02-06 - 1 citationsIntegration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma.Kelsey S Lau-Min, Heather Symecko, Kelsey Spielman, Derek Mann, Ryan Hood
JCO Oncology Practice. 2025-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: